Edmond de Rothschild Holding’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Edmond de Rothschild Holding’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,382	Closed	-$22.6K	–	670
2024 Q2	$22.6K	Hold	4,382	–	–	﹤0.01%	606
2024 Q1	$23.4K	Hold	4,382	–	–	﹤0.01%	612
2023 Q4	$34.1K	Hold	4,382	–	–	﹤0.01%	604
2023 Q3	$17.3K	Hold	4,382	–	–	﹤0.01%	637
2023 Q2	$13.8K	Hold	4,382	–	–	﹤0.01%	668
2023 Q1	$11.7K	Hold	4,382	–	–	﹤0.01%	679
2022 Q4	$15.7K	Hold	4,382	–	–	﹤0.01%	727
2022 Q3	$28K	Buy	+4,382	New	+$35.6K	﹤0.01%	722

Other funds holding SYRS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Edmond de Rothschild Holding's SYRS Position: Q3 2024 in Review

Edmond de Rothschild Holding sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q3 2024, closing a stake of 4,382 shares — an estimated $22.6K sold.

Edmond de Rothschild Holding first reported a position in SYRS in Q3 2022 and held it in 8 quarters. The position peaked at $34.1K in Q4 2023. 65 funds tracked by Wall St. Rank hold SYRS as of Q3 2024.

Edmond de Rothschild Holding reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Edmond de Rothschild Holding sold 4,382 Syros Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $22.6K.
Edmond de Rothschild Holding first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 8 quarters.
Edmond de Rothschild Holding's Syros Pharmaceuticals, Inc. Common Stock position peaked at $34.1K in Q4 2023.
65 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2024, filed 14 Nov 2024.